Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript
Authors:
- Lara WahlsterLWLara Wahlster
- Jeffrey M. VerboonJVJeffrey M. Verboon
- Leif S. LudwigLLLeif S. Ludwig
- Susan C. BlackSBSusan C. Black
- Wendy LuoWLWendy Luo
- Kopal GargKGKopal Garg
- Richard A. VoitRVRichard A. Voit
- Ryan L. CollinsRCRyan L. Collins
- Kiran GarimellaKGKiran Garimella
- Maura CostelloMCMaura Costello
- Katherine R. ChaoKCKatherine R. Chao
- Julia K. GoodrichJGJulia K. Goodrich
Open Access
- 15 April 2021
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Abstract
Advances in genome sequencing have resulted in the identification of the causes for numerous rare diseases. However, many cases remain unsolved with standard molecular analyses. We describe a family presenting with a phenotype resembling inherited thrombocytopenia 2 (THC2). THC2 is generally caused by single nucleotide variants that prevent silencing of ANKRD26 expression during hematopoietic differentiation. Short-read whole-exome and genome sequencing approaches were unable to identify a causal variant in this family. Using long-read whole-genome sequencing, a large complex structural variant involving a paired-duplication inversion was identified. Through functional studies, we show that this structural variant results in a pathogenic gain-of-function WAC-ANKRD26 fusion transcript. Our findings illustrate how complex structural variants that may be missed by conventional genome sequencing approaches can cause human disease.Keywords
Funding Information
- Lodish Family
- National Institutes of Health (R01 DK103794, R01 HL146500)
- Broad Institute
- National Eye Institute
- National Heart, Lung, and Blood Institute (UM1 HG008900)
- National Human Genome Research Institute (R01 HG009141)
- Seventh Framework Programme (282510)
- New York Stem Cell Foundation
This publication has 27 references indexed in Scilit:
- The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practiceBlood, 2017
- 5’UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemiaJournal of Hematology & Oncology, 2017
- The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and DiscoveryCell, 2016
- Paired-Duplication Signatures Mark Cryptic Inversions and Other Complex Structural VariationThe American Journal of Human Genetics, 2015
- Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivationJournal of Clinical Investigation, 2014
- Full-length RNA-seq from single cells using Smart-seq2Nature Protocols, 2014
- Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 familiesBlood, 2011
- Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartmentsBlood, 2011
- Mutations in the 5′ UTR of ANKRD26, the Ankirin Repeat Domain 26 Gene, Cause an Autosomal-Dominant Form of Inherited Thrombocytopenia, THC2The American Journal of Human Genetics, 2011
- Lineage-Specific Hematopoietic Growth FactorsNew England Journal of Medicine, 2006